Erleada

Erleada Indications/Uses

apalutamide

Manufacturer:

Janssen-Cilag

Distributor:

DKSH
Full Prescribing Info
Indications/Uses
ERLEADA is indicated for the treatment of patients with Metastatic castration-sensitive prostate cancer (mCSPC); Non-metastatic, castration-resistant prostate cancer (nmCRPC).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in